牛津大学惠康人类遗传学研究中心和中国医学科学院牛津研究所的张平博士为该研究论文的第一作者和通讯作者,Julian C. Knight教授为并列通讯作者。惠康人类遗传学研究中心Harindra E. Amarasinghe,Justin P. Whalley,Chwen Tay, Gabriele Migliorini,Andrew Brown,Alice Allcock,Giuseppe Scozzafava,Phalguni Rath,Benjamin Davies博士以及上海交通大学医学院附属瑞金医院的方海研究员是该论文的合作作者。张平博士的主要研究是通过表观基因组学、表达数量性状位点分析深入了解免疫相关疾病的遗传异质性和不同细胞在免疫应答过程中的相互作用,发现疾病关键易感位点并进行药物靶标识别,推动更完善的个性化治疗。
参考文献:
1. DeNardo DG, Ruffell B: Macrophages as regulators of tumour immunity and immunotherapy. Nature Reviews Immunology 2019, 19:369-382.
2.Varol C, Mildner A, Jung S: Macrophages: development and tissue specialization. Annu Rev Immunol 2015, 33:643-675.
3.Wynn TA, Chawla A, Pollard JW: Macrophage biology in development, homeostasis and disease. Nature 2013, 496:445-455.
4.Biswas SK, Lopez-Collazo E: Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009, 30:475-487.
5.Novakovic B, Habibi E, Wang SY, Arts RJW, Davar R, Megchelenbrink W, Kim B, Kuznetsova T, Kox M, Zwaag J, et al: beta-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance. Cell 2016, 167:1354-1368.
6.Thakore PI, D'Ippolito AM, Song L, Safi A, Shivakumar NK, Kabadi AM, Reddy TE, Crawford GE, Gersbach CA: Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat Methods 2015, 12:1143-1149.